World copd day 18 november 2015: experts highlight life-threatening copd is on the rise in kuwait but can be prevented
On World COPD Day on 18th November 2015, experts are prompting Kuwait citizens to inform themselves about persistent obstructive lung condition (COPD) and comprehend the threat elements with the hope of slowing the enhancing occurrence of this life-threatening condition.
That was the message from the Kuwait National Respiratory Forum, an unique conference hosted by AstraZeneca Gulf that bought together experts in respiratory medicine to try to find ways to deal with COPD and other respiratory conditions throughout the region.
COPD is a term for a variety of conditions consisting of emphysema and chronic bronchitis. Emphysema affects the lungs' air sacs and persistent bronchitis impacts the respiratory tracts. Individuals with COPD can have one or both of these conditions, which cause breathing difficulties such as breathlessness and chronic cough, and is responsible for three million deaths each year worldwide.1.
Professor Moussa Khadadah, Professor of Medicine at Kuwait University and Head of Respiratory Unit at Mubarak Hospital said COPD represents a significant public health issue in countries like the Kuwait. "COPD has a significant personal, social and economic impact," Professor Khadadah stated.
"Daily activities, such as strolling up a brief flight of stairs or carrying a bag of shopping, can end up being really hard as the condition slowly worsens," Professor Khadadah said.
"Unfortunately, there is no cure for COPD, but there are lots of treatments readily available to assist handle the condition and enhance signs. Individuals experiencing any unusual breathing must see their physician for a lung test," Professor Khadadah encouraged.
COPD is confirmed by a diagnostic test called spirometry that measures just how much air a person can breathe in and breathe out, and how quick air can move into and out of the lungs.
The Kuwait National Respiratory Forum is the first of a series of events held throughout the region and hosted by AstraZeneca Gulf as part of its commitment to improving results for people with respiratory diseases staying in the Gulf area.
